

[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI

[ Mon, Mar 04th 2024
] - WOPRAI

[ Mon, Feb 05th 2024
] - WOPRAI

[ Wed, Jan 17th 2024
] - WOPRAI

[ Tue, Nov 07th 2023
] - WOPRAI

[ Thu, Aug 10th 2023
] - WOPRAI

[ Wed, Apr 19th 2023
] - WOPRAI

[ Fri, Mar 03rd 2023
] - WOPRAI
[ Fri, Mar 03rd 2023
] - WOPRAI

[ Thu, Mar 02nd 2023
] - WOPRAI

[ Wed, Mar 01st 2023
] - WOPRAI

[ Wed, Nov 16th 2022
] - WOPRAI

[ Fri, Nov 04th 2022
] - WOPRAI

[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI

[ Tue, Aug 02nd 2022
] - WOPRAI

[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI

[ Thu, May 19th 2022
] - WOPRAI

[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI

[ Thu, Apr 21st 2022
] - WOPRAI

[ Mon, Mar 07th 2022
] - WOPRAI

[ Tue, Mar 01st 2022
] - WOPRAI

[ Tue, Dec 14th 2021
] - WOPRAI
[ Tue, Dec 14th 2021
] - WOPRAI

[ Tue, Nov 09th 2021
] - WOPRAI

[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI

[ Thu, Nov 19th 2020
] - WOPRAI

[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI

[ Mon, Dec 16th 2019
] - WOPRAI

[ Wed, Jan 03rd 2018
] - WOPRAI

[ Fri, May 06th 2016
] - WOPRAI

[ Wed, Jan 07th 2015
] - WOPRAI

[ Wed, Mar 13th 2013
] - WOPRAI

[ Wed, Oct 10th 2012
] - WOPRAI
Nathan Rich Maintained (AMRX) at Strong Buy with Increased Target to $8 on, May 6th, 2024
Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Increased Target from $6.25 to $8 on, May 6th, 2024.
Nathan has made no other calls on AMRX in the last 4 months.
There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with Nathan's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Nathan
- David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $8 on, Thursday, March 21st, 2024
- Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $8 on, Monday, January 29th, 2024